94.30MMarket Cap-11.74P/E (TTM)
0.950High0.904Low19.84KVolume0.915Open0.920Pre Close18.18KTurnover0.02%Turnover RatioLossP/E (Static)104.31MShares1.31052wk High8.29P/B90.23MFloat Cap0.50052wk Low--Dividend TTM99.81MShs Float3.780Historical High--Div YieldTTM5.02%Amplitude0.500Historical Low0.916Avg Price1Lot Size
Zentek Stock Forum
Zentek's ZenGUARD Air Filters Pass Critical Medical Device Test: 20-Month Stability Confirmed
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
Zentek Subsidiary Albany Graphite Corp. Simplifies Process to Achieve Five Nines Purity
Wednesday, 8th January at 9:10 am
GUELPH, ON / ACCESSWIRE / January 8, 2025 / Zentek Ltd.("Zentek" or the "Company") (NASDAQ: ZTEK)(TSXV: ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a preliminary five-nines purity of 99.9991% directly from a larg...
Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price
ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence
Zentek (NASDAQ:ZTEK) announces plans to add ZenGUARD™ Enhanced Air Filters under its existing medical device establishment licence (MDEL). Independent testing showed the filters achieve ~66% viral filtration efficiency enhancement compared to untreated filters, maintaining ~67% VFE over 6 months with minimal pressure drop changes. A ParticleOne study d...
📊⚡️📊
Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks
Zentek (NASDAQ:ZTEK)(TSXV:ZEN) has provided an update on the commercialization of its ZenGUARD™ Antimicrobial Surgical Masks. Following a Canada-wide sampling program for dental professionals through Henry Schein Inc., the company is experiencing increased demand for its product. Zentek is exploring opportunities in the beauty space and international healthcare markets. The company has applied to the...
NEWS
Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology
Zentek announces that its subsidiary, Triera Biosciences , has achieved positive results against avian influenza (H5N1) using multivalent aptamer technology. The development of a prophylaxis and therapeutic for highly pathogenic avian influenza has been prioritized, with promising initial test results. The binding affinity of the influenza aptamer...
Larger Image: tradingview.com...
$Zentek (ZTEK.US)$
No comment yet